WallStreetZenWallStreetZen

NASDAQ: CARA
Cara Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CARA

Based on 4 analysts offering 12 month price targets for Cara Therapeutics Inc.
Min Forecast
$1.00+44.93%
Avg Forecast
$4.63+570.29%
Max Forecast
$10.00+1,349.28%

Should I buy or sell CARA stock?

Based on 4 analysts offering ratings for Cara Therapeutics Inc.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CARA stock forecasts and price targets.

CARA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2023-12-19
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is CARA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is CARA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CARA revenue forecast

What is CARA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$7.3M-65.28%
Avg 2 year Forecast
$8.1M-61.49%
Avg 3 year Forecast
$9.0M-56.93%
CARA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CARA revenue growth forecast

How is CARA forecast to perform vs Biotechnology companies and vs the US market?
Company
-24.56%
Industry
37.96%
Market
10.23%
CARA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CARA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CARA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CARA$0.69$4.63+570.29%Buy
ESLA$1.03N/AN/A
UNCY$1.09$5.63+416.06%Strong Buy
PMN$2.00N/AN/A
OKYO$1.47$7.00+377.82%Buy
View Top Biotech Stocks

Cara Therapeutics Stock Forecast FAQ

Is Cara Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CARA) stock is to Buy CARA stock.

Out of 4 analysts, 1 (25%) are recommending CARA as a Strong Buy, 2 (50%) are recommending CARA as a Buy, 1 (25%) are recommending CARA as a Hold, 0 (0%) are recommending CARA as a Sell, and 0 (0%) are recommending CARA as a Strong Sell.

If you're new to stock investing, here's how to buy Cara Therapeutics stock.

What is CARA's revenue growth forecast for 2024-2026?

(NASDAQ: CARA) Cara Therapeutics's forecast annual revenue growth rate of -24.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Cara Therapeutics's revenue in 2024 is $20,968,000.On average, 3 Wall Street analysts forecast CARA's revenue for 2024 to be $397,898,687, with the lowest CARA revenue forecast at $108,219,698, and the highest CARA revenue forecast at $746,606,602. On average, 2 Wall Street analysts forecast CARA's revenue for 2025 to be $441,350,535, with the lowest CARA revenue forecast at $196,763,087, and the highest CARA revenue forecast at $685,937,983.

In 2026, CARA is forecast to generate $493,547,409 in revenue, with the lowest revenue forecast at $81,984,620 and the highest revenue forecast at $905,110,199.

What is CARA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CARA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CARA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CARA price target, the average CARA price target is $4.63, with the highest CARA stock price forecast at $10.00 and the lowest CARA stock price forecast at $1.00.

On average, Wall Street analysts predict that Cara Therapeutics's share price could reach $4.63 by Apr 10, 2025. The average Cara Therapeutics stock price prediction forecasts a potential upside of 570.29% from the current CARA share price of $0.69.

What is CARA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CARA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.